comment on this article

PragmatIC and Schreiner MediPharm announce strategic partnership

PragmatIC and Schreiner MediPharm have entered into a strategic partnership to add smart labels based on PragmatIC’s ConnectIC family of flexible integrated circuits into Schreiner MediPharm’s product portfolio.

“PragmatIC’s unique solutions will enable us to add connectivity and intelligence to a much wider range of products than was previously possible”, said Dr Thomas Schweizer, President of Schreiner MediPharm. “We are developing innovative smart labels for packaging and multiple device types that will improve usability and safety for both patients and healthcare professionals.”

ConnectIC devices make use of RFID, a technology that offers the pharmaceutical industry a variety of applications through the assignment of a unique ID, which is practically non-reproducible. It can be used for secure identification and traceability of individual products in devices and processes. These can also be produced ultra-thin and flexible, which makes them suitable for embedding into a wide range of substrates used for the labels of Schreiner MediPharm.

“This partnership with Schreiner MediPharm highlights how our ground-breaking ConnectIC product line is set to accelerate the deployment of RFID-based digital solutions in the healthcare sector,” commented Scott White, CEO of PragmatIC. “We are really pleased to see adoption of our technology by leading global suppliers like Schreiner MediPharm and look forward to working closely with them to develop new use cases for their products.”

Author
Charlotte Hathway

Comment on this article


This material is protected by MA Business copyright See Terms and Conditions. One-off usage is permitted but bulk copying is not. For multiple copies contact the sales team.

What you think about this article:


Add your comments

Name
 
Email
 
Comments
 

Your comments/feedback may be edited prior to publishing. Not all entries will be published.
Please view our Terms and Conditions before leaving a comment.

Related Articles